Last reviewed · How we verify
NCT04920058: CGM
Optimal Metabolic Health Through Continuous Glucose Monitoring
NA trial testing Continuous Glucose Monitor in Metabolic Syndrome in 66 participants. Completed in 18 April 2022.
18 April 2022
Quick facts
| Lead sponsor | University of South Florida |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 66 |
| Start date | 10 May 2021 |
| Primary completion | 18 April 2022 |
| Estimated completion | 18 April 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Continuous Glucose Monitor
- <Active Comparator?>
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
University of South Florida
Who can join
Adults 18 to 69, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary focus of this study is to evaluate the role of Continuous Glucose Monitoring (CGM) with Levels Health software as a tool to provide feedback and accountability necessary to create sustainable behavioral changes in nutrition associated with improved metabolic health and resilience against chronic and infectious diseases.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04920058
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Continuous Glucose Monitor
Trials testing the same drug.
- NCT07221812 — Continuous Glucose Monitors (CGMs) and Readmission Rates · NA · not yet recruiting
- NCT05548205 — Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge · NA · recruiting
- NCT06643611 — Addressing Disparities in Diabetes Care · NA · completed
- NCT06501612 — Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7 · NA · completed
- NCT05317585 — Continuous Glucose Monitor Use in Pregnancy · NA · recruiting
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other University of South Florida trials
Trials by the same sponsor.
- NCT07529366 — Pharmacist-Led Continuous Glucose Monitoring for Prediabetes · recruiting
- NCT07342569 — The WeACT Program for Family Caregivers of People Living With Dementia · NA · not yet recruiting
- NCT07502378 — Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic · Phase 4 · recruiting
- NCT07241260 — Hydrate Heroes for Improving Brain Function & Mood · NA · not yet recruiting
- NCT06377215 — Understanding Aided Speech Perception in Noise · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04920058 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Florida
- Last refreshed: 15 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04920058.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing